ARTICLE | Company News
Shionogi sales and marketing update
October 6, 2014 7:00 AM UTC
Shionogi's C&O Pharmaceutical Technology (Holdings) Ltd. subsidiary launched rabeprazole sodium for injection in China to treat peptic ulcers. The company said the proton-pump inhibitor (PPI) is the ...